|
|
Article: Tenby Pharma emerges with $25M financing.(Tenby Pharma)(Sirion Therapeutics)(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- September 25, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Florida, USA-based Tenby Pharma has announced its acquisition of Sirion Therapeutics as a wholly-owned subsidiary. From Tenby's inception until the consummation of the Sirion acquisition, the former was a shell company with no business or operations and only nominal assets. Pursuant to the transaction, Sirion's former stockholders acquired control of Tenby, which became the parent holding company for Sirion and its businesses. Additionally, in connection with this transaction, Tenby secured $25.0 million in financing from funds affiliated with North Sound Capital to develop and commercialize the Sirion portfolio of products.
It is anticipated that Tenby Pharma ...
Related newspaper, magazine, and journal articles:
|
|
Article: Sirion Therapeutics Announces Clinical Data to be ...
PR Newswire;
April 23, 2007 ;
700+ words
... ... April 23 /PRNewswire/ -- Sirion Therapeutics announced today that data on two ... President and Chief Executive Officer of Sirion Therapeutics. "This is exciting news for our ... ophthalmic therapies for unmet needs." Sirion Therapeutics Reception for all ARVO attendees ...
|
|